Author: Bournazos, Stylianos; Gupta, Aaron; Ravetch, Jeffrey V.
Title: The role of IgG Fc receptors in antibody-dependent enhancement Cord-id: agr6emyc Document date: 2020_8_11
ID: agr6emyc
Snippet: Antibody-dependent enhancement (ADE) is a mechanism by which the pathogenesis of certain viral infections is enhanced in the presence of sub-neutralizing or cross-reactive non-neutralizing antiviral antibodies. In vitro modelling of ADE has attributed enhanced pathogenesis to Fcγ receptor (FcγR)-mediated viral entry, rather than canonical viral receptor-mediated entry. However, the putative FcγR-dependent mechanisms of ADE overlap with the role of these receptors in mediating antiviral protec
Document: Antibody-dependent enhancement (ADE) is a mechanism by which the pathogenesis of certain viral infections is enhanced in the presence of sub-neutralizing or cross-reactive non-neutralizing antiviral antibodies. In vitro modelling of ADE has attributed enhanced pathogenesis to Fcγ receptor (FcγR)-mediated viral entry, rather than canonical viral receptor-mediated entry. However, the putative FcγR-dependent mechanisms of ADE overlap with the role of these receptors in mediating antiviral protection in various viral infections, necessitating a detailed understanding of how this diverse family of receptors functions in protection and pathogenesis. Here, we discuss the diversity of immune responses mediated upon FcγR engagement and review the available experimental evidence supporting the role of FcγRs in antiviral protection and pathogenesis through ADE. We explore FcγR engagement in the context of a range of different viral infections, including dengue virus and SARS-CoV, and consider ADE in the context of the ongoing SARS-CoV-2 pandemic.
Search related documents:
Co phrase search for related documents- absence presence and acute lung injury: 1, 2, 3
- absence presence and acute viral infection: 1, 2, 3
- absence presence and adaptive immunity: 1, 2, 3, 4
- activating balance and adaptive immunity: 1
- activating receptor and acute lung injury: 1, 2
- activating receptor and adaptive immunity: 1, 2, 3
- activation recruitment and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9
- activation recruitment and adaptive immunity: 1, 2, 3, 4, 5
- activation signal and acute lung injury: 1, 2, 3, 4, 5
- activation signal and adaptive immunity: 1, 2, 3
- acute lung injury and adaptive antiviral immunity: 1
- acute lung injury and adaptive immunity: 1, 2, 3, 4, 5, 6
- acute viral infection and adaptive immunity: 1, 2
Co phrase search for related documents, hyperlinks ordered by date